OBJECTIVES: To measure prevalence and risk factors for cervical infections among a large sample of women consulting for vaginal discharge in west Africa and to evaluate its syndromic management through a two visit algorithm. METHODS: In 11 health centres in Bénin, Burkina Faso, Ghana, Guinée, and Mali 726 women who presented with a vaginal discharge without abdominal pain and who denied being a sex worker (SW) were enrolled. Cervical samples were tested for the detection of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) with polymerase chain reaction (PCR) assays. All participants were treated with single dose (2 g) metronidazole and clotrimazole cream for 3 days. They were randomised to be told either to come back on day 7 only if there was no improvement in the discharge (group A), or to come back on day 7 regardless of response to treatment (group B). RESULTS: Overall, the prevalence of NG and CT was only 1.9% (14/726) and 3.2% (23/726) respectively. Risk factors previously recommended by the WHO were not associated with the presence of cervical infection, with the exception of the number of sex partners in the past 3 months. When taken together, these risk factors had a positive predictive value of only 6.4% to identify cervical infections. Prevalence of cervical infection was not higher in women who came back on day 7, regardless of the strategy used. Prevalence of NG/CT was lower in Ghana and Bénin (5/280, 1.8%), where comprehensive interventions for SW have been ongoing for years, than in the three other countries (27/446, 6.1%, p = 0.01). CONCLUSIONS: NG and CT infections are uncommon in west African women who consult for vaginal discharge and who are not SW. Syndromic management of vaginal discharge should focus on the proper management of vaginitis. The control of gonococcal and chlamydial infection should be redesigned around interventions focusing on sex workers.
RCT Entities:
OBJECTIVES: To measure prevalence and risk factors for cervical infections among a large sample of women consulting for vaginal discharge in west Africa and to evaluate its syndromic management through a two visit algorithm. METHODS: In 11 health centres in Bénin, Burkina Faso, Ghana, Guinée, and Mali 726 women who presented with a vaginal discharge without abdominal pain and who denied being a sex worker (SW) were enrolled. Cervical samples were tested for the detection of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) with polymerase chain reaction (PCR) assays. All participants were treated with single dose (2 g) metronidazole and clotrimazole cream for 3 days. They were randomised to be told either to come back on day 7 only if there was no improvement in the discharge (group A), or to come back on day 7 regardless of response to treatment (group B). RESULTS: Overall, the prevalence of NG and CT was only 1.9% (14/726) and 3.2% (23/726) respectively. Risk factors previously recommended by the WHO were not associated with the presence of cervical infection, with the exception of the number of sex partners in the past 3 months. When taken together, these risk factors had a positive predictive value of only 6.4% to identify cervical infections. Prevalence of cervical infection was not higher in women who came back on day 7, regardless of the strategy used. Prevalence of NG/CT was lower in Ghana and Bénin (5/280, 1.8%), where comprehensive interventions for SW have been ongoing for years, than in the three other countries (27/446, 6.1%, p = 0.01). CONCLUSIONS:NG and CT infections are uncommon in west African women who consult for vaginal discharge and who are not SW. Syndromic management of vaginal discharge should focus on the proper management of vaginitis. The control of gonococcal and chlamydial infection should be redesigned around interventions focusing on sex workers.
Authors: J Pépin; F Sobéla; S Deslandes; M Alary; K Wegner; N Khonde; F Kintin; A Kamuragiye; M Sylla; P J Zerbo; E Baganizi; A Koné; F Kane; B Mâsse; P Viens; E Frost Journal: Bull World Health Organ Date: 2001 Impact factor: 9.408
Authors: K Fonck; N Kidula; W Jaoko; B Estambale; P Claeys; J Ndinya-Achola; P Kirui; J Bwayo; M Temmerman Journal: Sex Transm Infect Date: 2000-02 Impact factor: 3.519
Authors: M Shaw; M van der Sande; B West; K Paine; S Ceesay; R Bailey; G Walraven; L Morison; K McAdam Journal: Sex Transm Infect Date: 2001-10 Impact factor: 3.519
Authors: C Costello Daly; A M Wangel; I F Hoffman; J K Canner; G S Lule; V M Lema; N G Liomba; G A Dallabetta Journal: Sex Transm Infect Date: 1998-06 Impact factor: 3.519
Authors: M J Wawer; N K Sewankambo; D Serwadda; T C Quinn; L A Paxton; N Kiwanuka; F Wabwire-Mangen; C Li; T Lutalo; F Nalugoda; C A Gaydos; L H Moulton; M O Meehan; S Ahmed; R H Gray Journal: Lancet Date: 1999-02-13 Impact factor: 79.321
Authors: J Pépin; A-C Labbé; N Khonde; S Deslandes; M Alary; A Dzokoto; C Asamoah-Adu; H Méda; E Frost Journal: Sex Transm Infect Date: 2005-02 Impact factor: 3.519
Authors: V Patel; H A Weiss; D Mabey; B West; S D'Souza; V Patil; P Nevrekar; S Gupte; B R Kirkwood Journal: Sex Transm Infect Date: 2006-06 Impact factor: 3.519
Authors: Koleka Mlisana; Nivashnee Naicker; Lise Werner; Lindi Roberts; Francois van Loggerenberg; Cheryl Baxter; Jo-Ann S Passmore; Anneke C Grobler; A Willem Sturm; Carolyn Williamson; Katharina Ronacher; Gerhard Walzl; Salim S Abdool Karim Journal: J Infect Dis Date: 2012-04-19 Impact factor: 5.226
Authors: Augustina A Sylverken; Ellis Owusu-Dabo; Denis D Yar; Samson P Salifu; Nana Yaa Awua-Boateng; John H Amuasi; Portia B Okyere; Thomas Agyarko-Poku Journal: Ghana Med J Date: 2016-09
Authors: Linnet Masese; Jared M Baeten; Barbra A Richardson; Ruth Deya; Emmanuel Kabare; Elizabeth Bukusi; Grace John-Stewart; Walter Jaoko; R Scott McClelland Journal: Sex Transm Dis Date: 2013-03 Impact factor: 2.830
Authors: Dzidzo Yirenya-Tawiah; Ted N Annang; Kwesi A Apea-Kubi; George Lomo; David Mensah; Lorenzo Akyeh; Kwabena M Bosompem Journal: BMC Res Notes Date: 2014-06-09